Keyphrases
Diabetes
100%
Methylglyoxal
96%
Streptozotocin
92%
Intravenous Solution
64%
Caveolin-1 (Cav-1)
64%
Endothelial Nitric Oxide Synthase (eNOS)
64%
Endothelial Dysfunction
64%
Pediatric Patients
64%
Inducible Nitric Oxide Synthase
57%
Vascular Dysfunction
51%
Pharmacology
44%
Streptozotocin-induced Diabetic Rats
40%
Kuwait
38%
Neuropathy
35%
Single Oral Dose
32%
Hypophosphataemia
32%
Potassium Chloride
32%
Bartter Syndrome
32%
Hypokalemia
32%
Diabetic Dyslipidemia
32%
Pediatric Poisoning
32%
Control Center
32%
Action Potential Configuration
32%
ADan
32%
SK Channels
32%
Atrial Myocytes
32%
Transient Receptor Potential Vanilloid 4 (TRPV4)
32%
Potassium Phosphate
32%
Rat Aorta
32%
Channel Activation
32%
Nitric Oxide Production
32%
Clinical Research
32%
Oral Dose
32%
Insulin Resistance
32%
Dysregulation
32%
Rat Model
32%
Poisoning
32%
Dapagliflozin
32%
Human Brain
32%
SH-SY5Y Cells
32%
Metformin
32%
Neuronal Cells
32%
Phosphatidylinositol 4,5-bisphosphate (PIP2)
32%
Oral Route
29%
Nasogastric Tube
29%
Diabetic
27%
Poisoning Cases
26%
Poison Control Centers
26%
Serum Potassium
24%
Atrial Fibrillation
24%
Pharmacology, Toxicology and Pharmaceutical Science
Streptozotocin
96%
Methylglyoxal
96%
Caveolin 1
64%
Endothelial Nitric Oxide Synthase
64%
Endothelial Dysfunction
64%
Diabetes Mellitus
58%
Neuronal Nitric Oxide Synthase
41%
Isotopes of Potassium
38%
Ion Channel
35%
Neuropathy
35%
Dyslipidemia
32%
Hypophosphatemia
32%
Nitric Oxide
32%
Small Conductance Calcium Activated Potassium Channel
32%
Bartter Syndrome
32%
Hypokalemia
32%
Potassium Chloride
32%
Clinical Research
32%
Syndrome
32%
Potassium Phosphate
32%
Rat Model
32%
Dapagliflozin
32%
Metformin
32%
Vascular Disease
32%
Lecithinase
32%
Atrial Fibrillation
24%
Infection
20%
Drug Administration
20%
Confocal Microscopy
19%
Molecular Pharmacology
16%
Age Related Macular Degeneration
16%
Clinical Toxicology
16%
Western Blot
16%
Molecular Pathology
16%
Enzyme-Linked Immunosorbent Assay
16%
Myocardial Disease
16%
Autosomal Recessive Disorder
14%
Urinary Tract Infection
14%
Route of Administration
14%
Heart Arrhythmia
14%
Hyperglycemia
13%
Oxidized Low Density Lipoprotein
12%
Gamma Interferon
12%
Inducible Nitric Oxide Synthase
12%
Lipopolysaccharide
12%
6,10 Diaza 3(1,3)8,(1,4) Dibenzena 1,5(1,4) Diquinolinacyclodecaphane
12%
Apamin
12%
Peroxynitrite
8%
Diabetic Complication
8%
Intravenous Route
8%
Medicine and Dentistry
Diabetes
93%
Caveolin 1
64%
Endothelial Nitric Oxide Synthase
64%
Streptozocin
64%
Endothelial Dysfunction
64%
Diabetes Mellitus
43%
Neuronal Nitric Oxide Synthase
41%
Ion Channel
35%
Pediatrics Patient
32%
Hypophosphatemia
32%
Potassium Dihydrogen Phosphate
32%
Methylglyoxal
32%
TRPV4
32%
Neuropathy
32%
Clinical Research
32%
Metabolite
32%
Dyslipidemia
32%
Medicine
32%
Calcium Imaging
19%
Aortic Endothelial Cell
16%
Pediatrics
16%
Clinical Toxicology
16%
Age Related Macular Degeneration
16%
Molecular Pathology
16%
Ligation
16%
Atrial Fibrillation
16%
Enzyme Linked Immunosorbent Assay
16%
Immunocytochemistry
16%
Electrophysiology
16%
Confocal Microscopy
16%
Myocardial Disease
16%
Western Blotting
16%
Cell Culture
16%
Lecithinase
16%
Permeability Barrier
16%
Inositol Phosphate
16%
Cannula
14%
Vasodilatation
13%
Body Weight
12%
Infection
12%
Drug Administration
12%
Oxidized Low Density Lipoprotein
12%
Intensive Care Unit
12%
Hyperglycemia
10%
Complications of Diabetes Mellitus
8%
Insulin Treatment
7%
Autosomal Recessive Disorder
6%
Nurse
6%
Urinary Tract Infection
6%
Arrhythmia
6%